2021 Q1 Form 10-Q Financial Statement

#000156459021025721 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2020 Q1
Revenue $123.9M $129.5M $107.7M
YoY Change 15.0% 43.9% 367.66%
Cost Of Revenue $93.44M $94.18M $41.23M
YoY Change 126.64% -9.39% 133.56%
Gross Profit $30.46M $35.28M $25.88M
YoY Change 17.69% 61.76% 380.58%
Gross Profit Margin 24.58% 27.25% 24.02%
Selling, General & Admin $34.23M $26.32M $45.60M
YoY Change -24.93% -59.04% 119.68%
% of Gross Profit 112.39% 74.6% 176.19%
Research & Development $1.202M $1.580M $1.347M
YoY Change -10.76% -5.39% 28.53%
% of Gross Profit 3.95% 4.48% 5.2%
Depreciation & Amortization $4.908M $4.420M $4.561M
YoY Change 7.61% -18.3% 64.54%
% of Gross Profit 16.12% 12.53% 17.62%
Operating Expenses $35.43M $31.26M $46.94M
YoY Change -24.52% -56.05% 115.3%
Operating Profit -$73.31M $4.023M -$71.25M
YoY Change 2.89% -101.86% 150.5%
Interest Expense -$7.943M $8.030M -$9.146M
YoY Change -13.15% -187.86% 4.6%
% of Operating Profit 199.6%
Other Income/Expense, Net -$220.3M -$72.65M -$4.651M
YoY Change 4637.48% -3844.79% -220.96%
Pretax Income -$252.3M -$5.040M -$185.1M
YoY Change 36.33% -97.76% 454.41%
Income Tax $6.310M -$14.19M -$970.0K
% Of Pretax Income
Net Earnings -$273.5M -$100.8M -$11.00M
YoY Change 2385.86% 1581.3% -62.54%
Net Earnings / Revenue -220.76% -77.87% -10.21%
Basic Earnings Per Share -$1.03 -$0.41 -$0.05
Diluted Earnings Per Share -$1.03 -$0.41 -$0.05
COMMON SHARES
Basic Shares Outstanding 265.4M 243.5M
Diluted Shares Outstanding 265.4M 243.5M

Balance Sheet

Concept 2021 Q1 2020 Q4 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $416.4M $189.7M $174.0M
YoY Change 139.31% 95.97% -46.53%
Cash & Equivalents $210.6M $148.2M $174.0M
Short-Term Investments
Other Short-Term Assets -$1.900M $22.50M $24.50M
YoY Change -107.76% -28.12% 353.7%
Inventory $96.54M $93.65M $95.59M
Prepaid Expenses $5.117M $6.542M $4.376M
Receivables $28.30M $29.03M $38.30M
Other Receivables $32.70M $12.20M $6.600M
Total Short-Term Assets $572.0M $347.0M $339.0M
YoY Change 68.74% 33.96% -15.17%
LONG-TERM ASSETS
Property, Plant & Equipment $197.8M $199.6M $187.0M
YoY Change 5.78% 8.33% 44.98%
Goodwill $169.1M $166.9M $159.6M
YoY Change 5.94% 2.24% 2.07%
Intangibles $186.2M $186.4M $187.9M
YoY Change -0.89% -18.52% -48.39%
Long-Term Investments $8.100M $9.300M $8.827M
YoY Change -8.24% -18.76% -55.19%
Other Assets $5.542M $4.400M $2.135M
YoY Change 159.58% -44.03% -73.31%
Total Long-Term Assets $596.3M $598.9M $576.6M
YoY Change 3.41% -6.03% -14.83%
TOTAL ASSETS
Total Short-Term Assets $572.0M $347.0M $339.0M
Total Long-Term Assets $596.3M $598.9M $576.6M
Total Assets $1.168B $945.9M $915.6M
YoY Change 27.59% 5.53% -14.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $48.29M $17.80M $23.90M
YoY Change 102.05% -54.5% 39.12%
Accrued Expenses $61.80M $41.40M $49.10M
YoY Change 25.87% -19.46% 43.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $49.50M $1.500M $4.700M
YoY Change 953.19% 1075.0%
Total Short-Term Liabilities $284.0M $181.3M $171.4M
YoY Change 65.69% 96.15% 0.61%
LONG-TERM LIABILITIES
Long-Term Debt $259.4M $306.3M $471.9M
YoY Change -45.03% -31.08% 9.36%
Other Long-Term Liabilities $34.90M $35.20M $34.00M
YoY Change 2.65% 522.79% 5939.08%
Total Long-Term Liabilities $294.3M $341.5M $505.9M
YoY Change -41.83% 5942.11% 89757.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $284.0M $181.3M $171.4M
Total Long-Term Liabilities $294.3M $341.5M $505.9M
Total Liabilities $627.6M $572.1M $725.3M
YoY Change -13.47% -6.38% 4.41%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $540.6M $373.9M $190.3M
YoY Change
Total Liabilities & Shareholders Equity $1.168B $945.9M $915.6M
YoY Change 27.59% 5.53% -14.95%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2020 Q1
OPERATING ACTIVITIES
Net Income -$273.5M -$100.8M -$11.00M
YoY Change 2385.86% 1581.3% -62.54%
Depreciation, Depletion And Amortization $4.908M $4.420M $4.561M
YoY Change 7.61% -18.3% 64.54%
Cash From Operating Activities -$13.01M -$24.86M -$54.03M
YoY Change -75.92% -72.62% 117.51%
INVESTING ACTIVITIES
Capital Expenditures $2.466M -$5.270M $18.29M
YoY Change -86.52% -80.67% 102.84%
Acquisitions
YoY Change
Other Investing Activities $2.400M $5.480M $170.0K
YoY Change 1311.76% -85.92% -100.11%
Cash From Investing Activities -$69.00K $200.0K -$18.12M
YoY Change -99.62% -98.28% -89.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $85.47M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 234.1M 54.73M 159.8M
YoY Change 46.5% -21.36% 21376.61%
NET CHANGE
Cash From Operating Activities -13.01M -24.86M -54.03M
Cash From Investing Activities -69.00K 200.0K -18.12M
Cash From Financing Activities 234.1M 54.73M 159.8M
Net Change In Cash 226.7M 30.07M 77.20M
YoY Change 193.62% -414.87% -139.99%
FREE CASH FLOW
Cash From Operating Activities -$13.01M -$24.86M -$54.03M
Capital Expenditures $2.466M -$5.270M $18.29M
Free Cash Flow -$15.47M -$19.59M -$72.32M
YoY Change -78.6% -69.17% 113.6%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Assets Current
AssetsCurrent
571969000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-71250000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25587000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27269000
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5542000
CY2021Q1 us-gaap Assets
Assets
1168244000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
48289000
CY2021Q1 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
60461000
CY2021Q1 tlry Accrued Lease Obligations Current
AccruedLeaseObligationsCurrent
2888000
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
49547000
CY2021Q1 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
tlry:OperatingLeaseLiabilityMember
CY2021Q1 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
tlry:FinanceLeaseLiabilityMember
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
197771000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
17478000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
186222000
CY2021Q1 us-gaap Goodwill
Goodwill
169079000
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
8100000
CY2021Q1 us-gaap Other Investments
OtherInvestments
12083000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-337202000
CY2021Q1 tlry Escrow Shares Released Value From Downstream Merger
EscrowSharesReleasedValueFromDownstreamMerger
135000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
156030000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3746000
CY2021Q1 tlry Shares Issued Value For Exercise Of Warrants
SharesIssuedValueForExerciseOfWarrants
337152000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
285271000
CY2020Q1 tlry Escrow Shares Released Value From Downstream Merger
EscrowSharesReleasedValueFromDownstreamMerger
151000
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
27027000
CY2020Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1079000
CY2020Q1 tlry Stock Issued During Period Value Registered Offering Net Of Issuance Costs
StockIssuedDuringPeriodValueRegisteredOfferingNetOfIssuanceCosts
19828000
CY2020Q1 tlry Shares Issued Value For Exercise Of Pre Funded Warrants
SharesIssuedValueForExerciseOfPreFundedWarrants
49054000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16707000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-340955000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
540631000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-340955000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-184123000
CY2021Q1 tlry Non Cash Inventory Valuation Adjustments
NonCashInventoryValuationAdjustments
2062000
CY2020Q1 tlry Non Cash Inventory Valuation Adjustments
NonCashInventoryValuationAdjustments
4044000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4908000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4561000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-200830000
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
29839000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7193000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7677000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
263201000
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
71978000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1787000
CY2021Q1 us-gaap Gross Profit
GrossProfit
13503000
CY2020Q1 us-gaap Gross Profit
GrossProfit
10870000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9739000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18326000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3498000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3591000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1787000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-184123000
CY2021Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
45000000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-73310000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
699000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-28069000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
263201000
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
71978000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000
CY2021Q1 tlry Income Loss From Equity Method Investments Measured At Fair Value
IncomeLossFromEquityMethodInvestmentsMeasuredAtFairValue
300000
CY2020Q1 tlry Income Loss From Equity Method Investments Measured At Fair Value
IncomeLossFromEquityMethodInvestmentsMeasuredAtFairValue
-1534000
CY2021Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
75000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-341212000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-185094000
CY2020Q1 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-65000
CY2020Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
221000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1516000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4651000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-635000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1272000
CY2021Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
378000
CY2020Q1 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
301000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-340955000
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-635000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-184123000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.01
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.73
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
169489223
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
106463352
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3753000
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16633000
CY2020Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-74000
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3753000
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16707000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
190308000
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1272000
CY2021Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1653000
CY2020Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2597000
CY2021Q1 tlry Amortization Of Transaction Costs On Senior Facility
AmortizationOfTransactionCostsOnSeniorFacility
436000
CY2020Q1 tlry Amortization Of Transaction Costs On Senior Facility
AmortizationOfTransactionCostsOnSeniorFacility
131000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
699000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
-28069000
CY2021Q1 tlry Accretion Related To Finance Lease Obligation
AccretionRelatedToFinanceLeaseObligation
-485000
CY2020Q1 tlry Accretion Related To Finance Lease Obligation
AccretionRelatedToFinanceLeaseObligation
-151000
CY2020Q1 tlry Issuance Costs On Registered Offering Recorded To Net Loss
IssuanceCostsOnRegisteredOfferingRecordedToNetLoss
3953000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
805000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46000
CY2021Q1 tlry Provisions For Sales Returns
ProvisionsForSalesReturns
-924000
CY2020Q1 tlry Provisions For Sales Returns
ProvisionsForSalesReturns
-262000
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-82000
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-457000
CY2020Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-138000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1000000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1906000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4893000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
11594000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2703000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-6749000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
30513000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-15218000
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
20645000
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3172000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13008000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-54031000
CY2020Q1 tlry Increase Decrease In Deposits And Other Assets
IncreaseDecreaseInDepositsAndOtherAssets
927000
CY2021Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
493000
CY2021Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
2719000
CY2020Q1 us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
437000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2466000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18290000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
171000
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
661000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18119000
CY2021Q1 tlry Proceeds From At The Market Equity Offering Net Of Costs
ProceedsFromAtTheMarketEquityOfferingNetOfCosts
156029000
CY2020Q1 tlry Proceeds From At The Market Equity Offering Net Of Costs
ProceedsFromAtTheMarketEquityOfferingNetOfCosts
27027000
CY2020Q1 tlry Proceeds From Profit Participation
ProceedsFromProfitParticipation
1353000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
85465000
CY2021Q1 tlry Payment Of Finance Liability
PaymentOfFinanceLiability
375000
CY2020Q1 tlry Payment Of Finance Liability
PaymentOfFinanceLiability
1000000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
76106000
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6117000
CY2020Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1813000
CY2020Q1 us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
105000
CY2021Q1 tlry Payment On Settlement Of Stock Options
PaymentOnSettlementOfStockOptions
2487000
CY2020Q1 tlry Payment On Settlement Of Stock Options
PaymentOnSettlementOfStockOptions
748000
CY2020Q1 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
46395000
CY2021Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
1309000
CY2020Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
414000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
234081000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
159786000
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5664000
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-10437000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
226668000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
77199000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
189702000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
96791000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
416370000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
173990000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24035000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
128889000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
161122000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23079000
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
8188000
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129855000
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
228358000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
227434000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30587000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
27875000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
197771000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
199559000
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
152923000
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.53%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company reclassified previously disclosed amounts related to inventory valuation adjustments and stock-based compensation expenses to conform with the disclosures as of March 31, 2021.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory valuation adjustments were previously disclosed as a separate component of cost of sales on the Company’s Consolidated Statements of Net Loss and Comprehensive Loss. As of March 31, 2021, these amounts are included under the caption of cost of sales. </p> <p style="margin-top:0pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the three months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ended March 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Inventory valuation adjustment no longer disclosed separately from cost of sales</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,044</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-top:0pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:0pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock-based compensation expenses was previously presented as a separate line item in the Company’s Consolidated Statements of Net Loss and Comprehensive Loss. As of March 31, 2021, the Company includes its stock-based compensation expense under the respective caption in financial statements where compensation paid to the same employees is recorded. These reclassifications are summarized as follows:</p> <p style="margin-top:0pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.02%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.06%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.88%; border-bottom:solid 0.75pt #000000;" valign="middle"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">For the three months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">ended March 31, 2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="middle"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,138</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9.5pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Sales and marketing expenses</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">450</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.02%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development expenses</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.06%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.88%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">89</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="margin-top:0pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;"> </p> <p style="margin-top:0pt;margin-bottom:0pt;text-indent:4.53%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The statement of net loss and comprehensive loss for the three months ended March 31, 2020 was reclassified to conform to the current period’s presentation. Acquisition-related expenses, net, formerly presented as a separate line item, is now presented in general and administrative expenses.</p>
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14243733
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14243733
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21266707
CY2021Q1 tlry Indefinite Lived Intangible Assets Excluding Goodwill Gross
IndefiniteLivedIntangibleAssetsExcludingGoodwillGross
57333000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21266707
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15263000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
15223000
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
60197000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
61867000
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21084000
CY2021Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
57333000
CY2020Q4 tlry Indefinite Lived Intangible Assets Excluding Goodwill Gross
IndefiniteLivedIntangibleAssetsExcludingGoodwillGross
83594000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
16555000
CY2021Q1 us-gaap Inventory Net
InventoryNet
96544000
CY2020Q4 us-gaap Inventory Net
InventoryNet
93645000
CY2020 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
27004000
CY2020Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
56590000
CY2021Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
210256000
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24035000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23079000
CY2021Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
9285000
CY2020Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
15976000
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5117000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6542000
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
16349000
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
12122000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
30751000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
34640000
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
186222000
CY2020Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
244716000
CY2021Q1 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
633000
CY2020Q4 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
477000
CY2021Q1 tlry Equity Investments Under Measurement Alternative
EquityInvestmentsUnderMeasurementAlternative
11450000
CY2020Q4 tlry Equity Investments Under Measurement Alternative
EquityInvestmentsUnderMeasurementAlternative
11392000
CY2020 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
35192000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
186445000
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2271000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1857000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
2500000
CY2021Q1 us-gaap Other Investments
OtherInvestments
12083000
CY2020Q4 us-gaap Other Investments
OtherInvestments
14369000
CY2021Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
300000
CY2020Q1 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-1534000
CY2021Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2020Q1 us-gaap Impairment Of Investments
ImpairmentOfInvestments
0
CY2021Q1 us-gaap Equity Method Investments
EquityMethodInvestments
8100000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1787000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
9300000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
887000
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
615000
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
805000
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
46000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
439000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
19000
CY2021Q1 tlry Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
-14000
CY2020Q1 tlry Accounts Receivable Allowance For Credit Loss Foreign Currency Translation
AccountsReceivableAllowanceForCreditLossForeignCurrencyTranslation
47000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1267000
CY2020Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
595000
CY2021Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
30298000
CY2020Q1 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
40057000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7684000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
9868000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9625000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9619000
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9589000
CY2021Q1 tlry Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
82504000
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
128889000
CY2020Q4 us-gaap Goodwill
Goodwill
166915000
CY2021Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
2164000
CY2021Q1 us-gaap Goodwill
Goodwill
169079000
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
27171000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
24181000
CY2021Q1 tlry Accrued Litigation Settlement
AccruedLitigationSettlement
20000000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9314000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9282000
CY2021Q1 us-gaap Interest Payable Current
InterestPayableCurrent
1158000
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
3473000
CY2021Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
905000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1091000
CY2021Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
413000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
419000
CY2021Q1 tlry Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
60461000
CY2020Q4 tlry Accrued Liabilities And Other Current Liabilities
AccruedLiabilitiesAndOtherCurrentLiabilities
39946000
CY2020Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
19000000
CY2021Q1 tlry Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
12791000
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
6209000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2861000
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
893000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3498000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
6165000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3351000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
12438000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
2758000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
2179000
CY2021Q1 tlry Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
6428000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
21075000
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
19496000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3260000
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
3902000
CY2021Q1 tlry Lessee Operating Lease Liability Before Accrued Lease Obligation Current
LesseeOperatingLeaseLiabilityBeforeAccruedLeaseObligationCurrent
17815000
CY2021Q1 tlry Finance Lease Liability Before Accrued Lease Obligation Current
FinanceLeaseLiabilityBeforeAccruedLeaseObligationCurrent
15594000
CY2021Q1 tlry Accrued Operating Lease Obligation Current
AccruedOperatingLeaseObligationCurrent
2888000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
14927000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
15594000
CY2021Q1 us-gaap Purchase Obligation
PurchaseObligation
17359000
CY2021Q1 us-gaap Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year
PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear
17359000
CY2021Q1 us-gaap Other Commitment
OtherCommitment
386346000
CY2021Q1 us-gaap Other Commitments Future Minimum Payments Remainder Of Fiscal Year
OtherCommitmentsFutureMinimumPaymentsRemainderOfFiscalYear
22200000
CY2021Q1 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
67897000
CY2021Q1 us-gaap Other Commitment Due In Second Year
OtherCommitmentDueInSecondYear
293249000
CY2021Q1 us-gaap Other Commitment Due In Third Year
OtherCommitmentDueInThirdYear
1500000
CY2021Q1 us-gaap Other Commitment Due In Fourth Year
OtherCommitmentDueInFourthYear
1500000
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0
CY2020Q1 tlry Loss On Disposal Of Property And Equipment
LossOnDisposalOfPropertyAndEquipment
457000
CY2021Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
66000
CY2020Q1 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
963000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25587000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27269000
CY2021Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
7613000
CY2020Q1 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6848000
CY2021Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
7013000
CY2020Q1 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
7296000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6493000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7138000
CY2021Q1 us-gaap Professional Fees
ProfessionalFees
3577000
CY2020Q1 us-gaap Professional Fees
ProfessionalFees
4521000
CY2021Q1 tlry Credit Loss Expenses
CreditLossExpenses
742000
CY2020Q1 tlry Credit Loss Expenses
CreditLossExpenses
46000
CY2021Q1 tlry Loss On Disposal Of Property And Equipment
LossOnDisposalOfPropertyAndEquipment
83000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
103000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
912000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
704000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
994000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
854000
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
264000
CY2020Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
142000
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
105000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
33000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
423000
CY2021Q1 tlry Change In Foreign Exchange Rate
ChangeInForeignExchangeRate
0.10
CY2021Q1 tlry Increase Decrease In Assets And Liabilities Due To Change In Exchange Rate
IncreaseDecreaseInAssetsAndLiabilitiesDueToChangeInExchangeRate
47220000
CY2021Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0805
CY2021Q1 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.05
CY2021Q1 tlry Change In Canadian Prime Rate
ChangeInCanadianPrimeRate
0.01
CY2021Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
134000
CY2021Q1 tlry Hypothetical Decrease In Fair Value Of Investments
HypotheticalDecreaseInFairValueOfInvestments
0.10
CY2021Q1 tlry Estimated Decrease In Fair Values Of Investments Upon Hypothetical Decrease In Prices
EstimatedDecreaseInFairValuesOfInvestmentsUponHypotheticalDecreaseInPrices
1132000
CY2021Q1 tlry Hypothetical Increase In Common Stock
HypotheticalIncreaseInCommonStock
0.10
CY2021Q1 tlry Estimated Increase In Fair Values Of Warrant Liability On Hypothetical Increase In Prices
EstimatedIncreaseInFairValuesOfWarrantLiabilityOnHypotheticalIncreaseInPrices
12290000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
2500000
CY2020Q4 tlry Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrant Liability
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantLiability
120647000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSettlements
-2500000
CY2021Q1 tlry Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrant Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantLiabilitySettlements
81223000
CY2021Q1 tlry Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrant Liability Change In Fair Value
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantLiabilityChangeInFairValue
-83380000
CY2021Q1 tlry Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Warrant Liability
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityWarrantLiability
122804000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48021000
CY2021Q1 us-gaap Gross Profit
GrossProfit
13503000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52102000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
197771000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
199559000
CY2020Q1 us-gaap Gross Profit
GrossProfit
10870000
CY2021Q1 us-gaap Gross Profit
GrossProfit
13503000
CY2020Q1 us-gaap Gross Profit
GrossProfit
10870000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25587000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27269000
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9739000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
18326000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1202000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1347000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3498000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3591000
CY2020Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
29839000
CY2021Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1787000
CY2020Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000
CY2021Q1 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
45000000
CY2021Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
699000
CY2020Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-28069000
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
263201000
CY2021Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-6916000
CY2020Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
71978000
CY2020Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-9146000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1516000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4651000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-341212000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-185094000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48021000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52102000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48021000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52102000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
48021000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
52102000
CY2021Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
4646000
CY2020Q1 us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
4972000

Files In Submission

Name View Source Status
0001564590-21-025721-index-headers.html Edgar Link pending
0001564590-21-025721-index.html Edgar Link pending
0001564590-21-025721.txt Edgar Link pending
0001564590-21-025721-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlry-10q_20210331.htm Edgar Link pending
tlry-10q_20210331_htm.xml Edgar Link completed
tlry-20210331.xsd Edgar Link pending
tlry-20210331_cal.xml Edgar Link unprocessable
tlry-20210331_def.xml Edgar Link unprocessable
tlry-20210331_lab.xml Edgar Link unprocessable
tlry-20210331_pre.xml Edgar Link unprocessable
tlry-ex311_7.htm Edgar Link pending
tlry-ex312_6.htm Edgar Link pending
tlry-ex321_8.htm Edgar Link pending